SCHEMBL9602320

SCHEMBL9602320

O=C(c1cccnc1)c1ccccc1C(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.51
▸ CNR2 P34972 2/20 0.49
▸ PLOD2 O00469 2/20 0.48
▸ PLOD3 O60568 1/20 0.48
▸ PLOD1 Q02809 1/20 0.48
▸ GAA P10253 2/20 0.47
▸ APP P05067 1/20 0.47
▸ HCAR3 P49019 1/20 0.47
▸ HCAR2 Q8TDS4 1/20 0.47
▸ LMNA P02545 1/20 0.46
▸ F7 P08709 1/20 0.46
▸ F3 P13726 1/20 0.46
▸ SARM1 Q6SZW1 1/20 0.46
▸ SIRT2 Q8IXJ6 1/20 0.46
▸ SIRT6 Q8N6T7 1/20 0.46
▸ SIRT1 Q96EB6 1/20 0.46
▸ SIRT3 Q9NTG7 1/20 0.46
▸ SIRT5 Q9NXA8 1/20 0.46
▸ SIRT4 Q9Y6E7 1/20 0.46
▸ ADORA2A P29274 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31369140 0.81 GAA (0.56) ALDH1A1CNR2GAALMNASMN1; SMN2
SCHEMBL3717986 0.81 GAA (0.56) ALDH1A1CNR2GAALMNASMN1; SMN2
SCHEMBL746794 0.77 LMNA (0.64) CNR2GAALMNASMN1; SMN2
SCHEMBL7289960 0.77 AKR1C3 (0.66) ALDH1A1PLOD2GAAAPPHCAR3
SCHEMBL22426419 0.77 ALDH1A1 (0.56) ALDH1A1PLOD2GAAAPPHCAR3
SCHEMBL9830800 0.76 ALDH1A1 (0.46) ALDH1A1PLOD2PLOD3PLOD1GAA
SCHEMBL3251235 0.76 ALDH1A1 (0.52) ALDH1A1PLOD2GAAAPPHCAR3
SCHEMBL6950942 0.76 GAA (0.65) ALDH1A1PLOD2GAAAPPHCAR3
SCHEMBL27951998 0.76 TBXAS1 (0.53) ALDH1A1PLOD2GAAAPPHCAR3
SCHEMBL6770549 0.76 HPGD (0.59) ALDH1A1PLOD2GAAAPPHCAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0221601-B1 [[[(3-Pyridinyl)methylen]amino]oxy]alkanoic acids and esters JANSSEN PHARMACEUTICA N.V. (BE) 1993-03-10 — — EP disclosed
US-5180832-A Chemical intermediate for thromboxane A2 inhibitor JANSSEN PHARMACEUTICA N.V. (BE) 1993-01-19 — — US disclosed
US-4963573-A INHIBIT BIOSYNTHESIS OF THROMBOXANE A2 JANSSEN PHARMACEUTICA N.V. (BE) 1990-10-16 — — US disclosed
US-4746671-A THROMBOXANE SYNTHETASE INHIBITION JANSSEN PHARMACEUTICA N.V. (BE) 1988-05-24 — — US disclosed
Send feedback